Mr. David John Jeans
Chairman
Board of Commitee
ProMetic Life Sciences
United Kingdom
Biography
Mr. David John Jeans, CBE, CEng, BSc MIChemE, is currently Chairman of Imanova, and Edinburgh Molecular Imaging, and a non-executive Director of Renishaw plc. He was previously the Chair of Cardiff University and a Director of the University Employers Association. From 2009 to 2011, Mr. Jeans was Deputy Chief Executive of the Medical Research Council, a member of its Audit and Risk Committee and Chaired the Trustee Board of MRC Technology until 2014. An advisor to public and third sector organizations, he was appointed by the Prime Minister of United Kingdom in 2014 as the Life Science Champion for medical technology. Mr. Jeans has lead Innovate UK’s Stratified Medicine Advisory Board since 2009 and the KTN’s Health Board since 2104, and has contributed to advisory panels for the MRC, EPSRC, NIHR and the Wellcome Trust. He serves on several Government bodies including the Ministerial Committee on Medical Technologies since 2012, was an inaugural member of the Science Advisory Council for Wales in 2012 and a founder Trustee of the Francis Crick Institute in 2010. He is also Chair of the Strategic Advisory Panel for the Singapore Government’s Diagnostics Hub since 2014. In an industrial career spanning 35 years, he held senior international leadership positions in global companies including Smith & Nephew, Bristol Myers Squibb, Johnson & Johnson and Amersham plc. Mr. Jeans headed the commercial function of GE’s Life Science business and was the Chairman of its UK Healthcare Company. His domain experience ranges from medical devices and therapeutic pharmaceuticals to in-vivo and invitro diagnostics; encompassing research, product development, manufacturing and commercialization. Mr. Jeans is engaged with international, national and local charities including the Africa Research Excellence Fund and the Clare Foundation. He was awarded the CBE for services to Life Sciences, Healthcare and Science in 2012.
Research Interest
m edical devices and therapeutic pharmaceuticals to in-vivo and invitro diagnostics; encompassing research, product development, manufacturing and commercialization.